Back to catalog
Single Research

DALDA (Tyr-D-Arg-Phe-Lys-NH2) dosing guide

DALDA (Dermorphin [D-Arg2, Lys4] analog) is a highly selective delta opioid receptor (DOR) agonist peptide. It's used in pain research and has potential applications in analgesia with reduced addiction potential compared to mu-opioid agonists.

Quickstart Highlights

  • Dosage: Research dosing
  • Frequency: Research plans
  • Administration: Research - injection
  • Cycle length: Research plans only

How This Works

DALDA selectively activates delta opioid receptors (DOR), which are distributed differently than mu opioid receptors. DOR activation produces analgesia, particularly for chronic and neuropathic pain, with potentially less respiratory depression and addiction liability than mu-opioid agonists. Delta receptors are also implicated in cardioprotection and neuroprotection.

Mechanism of Action

How DALDA Works in Your Body

1

Peptide Administered

Enters the bloodstream via injection

2

Receptor Binding

Finds and activates its target receptor

3

Signal Cascade

Triggers a chain of cellular responses

4

Biological Effect

The body produces the desired outcome

Receptor Binding

How peptides activate cellular receptors

  1. Approach
  2. Bind
  3. Activate

Benefits & Side Effects

Potential Benefits

  • Analgesia with reduced addiction risk
  • Pain research tool
  • Potential neuroprotection
  • Cardiac protection in ischemia research
  • Understanding opioid receptor pharmacology

Potential Side Effects

  • Opioid effects (sedation, etc.)
  • Research compound - unknown full profile
  • Not for human self-administration
  • Requires controlled research setting

Good to know

  • RESEARCH COMPOUND ONLY.
  • Selective delta opioid receptor (DOR) agonist.
  • DOR activation may cause less addiction than mu opioids.
  • Used in pain and opioid receptor research.
  • Not for self-administration.
  • Different from typical opioids like morphine.
  • May have neuroprotective properties.

Community Insights

Summarised from 2 sources

DALDA (Dermorphin [D-Arg2, Lys4] analog) is a highly selective delta opioid receptor (DOR) agonist peptide. It's used in pain research and has potential applications in analgesia with reduced addiction potential compared to mu-opioid agonists. Research compound. Delta opioid receptor agonist. Used i

Common Dosages Reported

  • Research dosing Research plans
  • Standard protocol dosing

Side Effects Mentioned

  • Generally mild, individual variation expected
  • See full guide for detailed safety info

Stacking Suggestions

  • Consult research and healthcare provider before stacking

What people are saying

Results vary based on individual response
Consistent dosing and timing important

Reviews & Discussion

Real experiences shared by the community — not medical advice.

Your rating:

Auto-moderated. Not medical advice.

No reviews yet — be the first.

Auto-moderated. Not medical advice.

No discussion yet — be the first.

Auto-moderated. Not medical advice.

No notes yet — be the first.